The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

Analysts said the deal with Novo was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Telehealth has been a lifeline for many healthcare organizations during the COVID-19 pandemic, but broader access to virtual care has also contributed to increased security challenges.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Once someone decides they need an abortion, they will go to great lengths to get one because they know it is the right ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...